Article
Pan-cancer analysis of prognostic metastatic phenotypes.
International journal of cancer - 1 Jan 2022
Zaorsky Nicholas G, Wang Xi, Garrett Sara M, Lehrer Eric J, Lin Christine, DeGraff David J, Spratt Daniel E, Trifiletti Daniel M, Kishan Amar U, Showalter Timothy N, Park Henry S, Yang Jonathan T, Chinchilli Vernon M, Wang Ming
Abstract excerpt
Although cancer is highly heterogeneous, all metastatic cancer is considered American Joint Committee on Cancer (AJCC) Stage IV disease. The purpose of this project was to redefine staging of metastatic cancer. Internal validation of nationally representative patient data from the National Cancer Database (n = 461 357; 2010-2013), and external validation using the Surveillance, Epidemiology and End Results...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
